Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease - Concepedia

Concepedia

Publication | Closed Access

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

281

Citations

54

References

2014

Year

Veronique Chachay, Graeme A. Macdonald, Jennifer Martin, Jonathan P. Whitehead, Trisha O'Moore‐Sullivan, Paul P. Lee, Michael E. Franklin, Kerenaftali Klein, Paul J. Taylor, Maree Ferguson,

Clinical Gastroenterology and Hepatology

ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyHepatitisPathologyHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyDrug-induced Liver InjuryOxidative StressHealth Sciences

References

	Year	Citations

Page 1

Page 1